Skip to content

The COMT Gene Your Complete Guide to Understanding, Testing, and Supporting It

The COMT Gene Your Complete Guide to Understanding, Testing, and Supporting It

There's a gene with over 6,000 published studies behind it that determines whether your brain holds onto dopamine, norepinephrine, and estrogen — or flushes them out before you even feel them working.22 It's called COMT (catechol-O-methyltransferase). And depending on which variant you carry, or how it’s performing epigenetically that day, it's either leaving you wired, restless, and overwhelmed — or drained, unmotivated, and wondering why nothing feels like it used to. It influences your pain tolerance, your stress response, your hormonal balance, and even your risk for conditions like fibromyalgia, panic disorder, and estrogen-driven cancers. Yet most doctors never test for it, most labs don't flag it, and most people spend years treating symptoms that trace straight back to this one gene. That ends here.

Meet Sarah — A Slow COMT Type

Sarah had always been the "intense" one. Her mind never stopped — replaying conversations, anticipating problems, lying awake until 2 a.m. running through tomorrow's to-do list in sharp, vigorous detail. She was the go-to-person at work. There were days when the tension headaches hit hard and her temper flared over things she knew didn't warrant it. She'd tried meditation apps, magnesium supplements her friend swore by, even therapy — and while those helped a little, the core wiring felt unchanged. Her doctor said her labs looked "normal." Her therapist said she was "just a Type A personality." What Sarah didn't realize was that the answer was sitting inside her DNA — in a gene called COMT.

Meet Jason — A Fast COMT Type

Jason was the opposite of restless — and not in a good way. Mornings were a fog. He needed two large coffees just to feel like a functioning person, and even then the focus never really locked in. His wife called him "even-keeled," but privately, he felt more like "flatlined." He'd scroll his phone for dopamine hits, eat sugar for a quick spark, and then crash again. But here's what confused everyone, including Jason: when the pressure was on, he was a different person. He'd procrastinate on a report for days, then crush it the night before the deadline. Home projects sat unfinished for weeks — until his in-laws were coming over and he'd knock out three in a single Saturday. He wasn't lazy. Unknowingly, he was starving for the neurochemical surge that only high-stakes moments could deliver. His doctor tested his thyroid — normal. His testosterone — normal. What Jason didn't realize was that his COMT enzyme was clearing his dopamine and norepinephrine so fast that his brain could barely hold onto them long enough to feel anything — until real pressure finally pumped out enough to overcome the drain.

What Does the COMT Gene Actually Do?

COMT is the gene that tells your body how to build an enzyme responsible for processing certain brain chemicals and hormones — specifically dopamine, norepinephrine, and epinephrine (your catecholamines), as well as estrogen metabolites [1].

Think of COMT as your brain’s cleanup crew. After your neurotransmitters deliver their message — focus, motivation, alertness, pleasure — COMT comes along and sweeps them away so you can reset and respond to the next thing clearly. It also helps clear used estrogen from your system by methylating catechol estrogens into inactive methoxyestrogens, which is why COMT has such a big impact on hormonal health [3].

When COMT works well, you feel focused but calm. Alert but not wired. Motivated but able to let go at the end of the day. When it doesn’t, either neurotransmitters and/or hormones pile up — or they get cleared too fast — and your mood, sleep, pain tolerance, and hormonal balance all suffer. COMT is one of the most impactful genes in your entire body because it sits at the intersection of your brain chemistry, your stress response, and your hormonal health.

How COMT Works — The Nutrients It Needs

COMT's cleanup process depends on methylation — one of the most fundamental reactions in your body. Methylation is simply the act of taking a methyl group (one carbon atom bonded to three hydrogen atoms) and attaching it to another molecule, which changes that molecule's structure and function. Your body performs billions of methylation reactions every day — turning genes on and off, building neurotransmitters, processing hormones, and detoxifying chemicals. In COMT's case, the enzyme takes a methyl group from SAM (S-adenosylmethionine) and attaches it to dopamine, norepinephrine, or estrogen to neutralize and clear them. No methyl group, no cleanup [4]. Too many methyl groups, too much cleanup.

To do this, COMT needs three things: SAM as the methyl donor, magnesium as a direct cofactor, and a substrate to act on — primarily dopamine, norepinephrine, and estrogen, which are all downstream of tyrosine, an amino acid you get from dietary protein.

Magnesium is non-negotiable. Without it, the enzyme can't function.[4] Animal research confirms this directly: magnesium deficiency decreases COMT activity in the liver, independent of other variables [5]. And in humans, we see the downstream consequences — women with preeclampsia show significantly suppressed COMT activity, and the standard medical treatment is intravenous magnesium sulfate [24]. Now consider that nearly half (48%) of the U.S. population consumes less than the required daily amount of magnesium from food alone [23] — and you start to see why so many people have a COMT gene that's acting dirty, even when the genetics look clean.

SAM, meanwhile, depends on its own supply chain: adequate methylfolate, methylcobalamin (active B12), and riboflavin (B2). If any of those are low, SAM production drops, and COMT has nothing to methylate with. This is where your MTHFR gene becomes critical — MTHFR produces the methylfolate that drives SAM production. If your MTHFR gene is dirty, your methylfolate output drops, your SAM levels fall, and now your COMT is starving for methyl groups regardless of which variant you carry. It's one of the clearest examples of how dirty genes don't act alone — a sluggish MTHFR can make your COMT dirty by cutting off its fuel supply.

But here's the nuance most people miss: the goal isn't to push COMT as hard as possible. It's to keep it running at the right speed. If COMT is too slow, neurotransmitters and estrogen build up — you feel wired, restless, or emotionally overwhelmed. If COMT is too fast, they get cleared too quickly — you feel flat, unmotivated, or unable to focus.

The same nutrients that support COMT can also accelerate it beyond what's ideal for your particular variant. More SAM, more magnesium, and less protein aren't always better — they're better when COMT is sluggish, and potentially problematic when it's already running fast. That means understanding your COMT variant, recognizing your current symptoms, and adjusting your nutrient intake accordingly — not just loading up on methylation support and hoping for the best.

When these inputs are dialed in — the right nutrients, in the right amounts, at the right times — COMT hums along, clearing neurotransmitters at the pace your brain and body actually need. When they're off — too low or too high — COMT gets dirty. The good news: this is one of the most adjustable genes in your body, once you understand what it needs and when it needs it.

What Makes COMT Dirty — Epigenetics

You can be “born dirty” with a COMT variant that changes how fast or slow your enzyme works. But you can also have perfectly normal COMT genetics and still have a dirty COMT — because your environment and lifestyle are interfering with the enzyme’s function.

Here’s what makes COMT dirty even without a genetic variant:

Nutrient depletion. Low magnesium, low B12, low folate, or low B2 all starve COMT of what it needs. Frequent stress burns through magnesium and methyl donors at an alarming rate, making this one of the most common causes of a functionally dirty COMT. Research confirms that COMT activity is directly proportional to magnesium concentration [5].

Excess catechols in the diet. Foods and beverages high in catechols — coffee, tea, chocolate, red wine — add to COMT's workload. They contain compounds that COMT must process, which means your enzyme is now doing double duty on dietary catechols instead of focusing on clearing dopamine and estrogen. Chemicals such as flavonoids, quercetin, and catechol-containing polyphenols are all COMT substrates that compete with endogenous catecholamines for the enzyme's attention [3]. This doesn't mean you need to eliminate these foods — they're loaded with beneficial compounds. But if you have a slow COMT and you're already feeling wired, restless, or emotionally reactive, stacking a pot of coffee on top of an enzyme that's already behind isn't helping. On the other hand, if your COMT runs fast, these foods can actually work in your favor by gently slowing the enzyme down and keeping neurotransmitters around a little longer. The key is context: a cup of coffee when you're feeling balanced is very different from three cups when you're already overstimulated.

Estrogen-mimicking compounds. BPA, phthalates, parabens in personal care products, and xenoestrogens in plastics all add to COMT's estrogen-clearing burden. But the problem goes beyond just workload — estrogen exposure can actually suppress COMT itself. Research on human placental tissue has shown that COMT activity varies significantly between individuals, and that catechol-containing compounds compete directly with estrogen metabolites for the enzyme's attention, effectively blocking COMT from clearing the estrogens it needs to [25]. In pregnant women, suppressed placental COMT activity has been linked to preeclampsia — a dangerous condition characterized by high blood pressure and organ damage [6]. When you layer daily xenoestrogen exposure from plastics, personal care products, and pesticides on top of an already slow COMT, you're flooding an enzyme that's already struggling to keep up.

Heavy metals. Lead and mercury can inhibit COMT enzyme function directly. Even low-level exposure matters.

Frequent psychological stress. Sustained stress keeps dopamine and norepinephrine pumping. COMT has to work harder and longer, and if you’re also depleting the nutrients it needs to function, you’re caught in a vicious cycle.

Medications. Certain medications alter catecholamine or estrogen metabolism and can increase the burden on COMT [24,25].

The point is this: your COMT gene might be perfectly fine on paper, but if your life is stacking the deck against it, it’s going to act dirty.

Common COMT Variants

The most clinically significant COMT variant is Val158Met (rs4680). This single SNP determines whether your COMT enzyme runs fast, slow, or somewhere in between. The substitution of valine (Val) to methionine (Met) at codon 158 changes the enzyme’s thermostability and, consequently, its activity level [7].

Met/Met (AA) — This is "slow COMT." The Met/Met genotype results in a three- to four-fold reduction in enzymatic activity compared with Val/Val [7, 8, 9]. Neurotransmitters and estrogen tend to accumulate. People with this variant often feel things intensely — they're focused, detail-oriented, and deeply alert, but also more prone to anxiety, insomnia, pain, rumination, and estrogen-related issues. Research has shown that those carrying the Met/Met variant derive the same level of subjective well-being from mildly pleasant events as those with the Val/Val variant, who require strongly pleasant events to achieve the same level of well-being [10].

Val/Val (GG) — This is what I call "fast COMT" in Dirty Genes. The Val variant processes dopamine up to four times the rate of the Met variant [7, 8]. The enzyme clears dopamine, norepinephrine, and estrogen quickly — sometimes too quickly. People with this variant may feel calm and easygoing, but they can also struggle with low motivation, flat mood, difficulty concentrating, and low estrogen symptoms. Their neurotransmitters get swept away almost too fast.

Val/Met (AG) — The heterozygous middle ground. These individuals have moderate enzyme activity and often adapt well, though they can tip toward either fast or slow behavior depending on their environment, stress, and nutrient status. The heterozygous genotype is considered clinically the “normal” level of dopamine degradation [2].

Population prevalence: Val158Met varies significantly by ancestry. Approximately 25% of European-descent populations are Met/Met (slow COMT), about 50% are Val/Met, and roughly 25% are Val/Val (fast COMT) [12]. In East Asian populations, the Met allele frequency tends to be lower, with more individuals carrying Val/Val. African-descent populations show intermediate frequencies [12]. A comprehensive meta-analysis covering 363 datasets found that the effects of COMT variants on psychiatric conditions also vary by ancestry and sex [13].

Why did Nature Give us Different Speeds?

Historically, when humans lived in tribes, it was useful to have people within the tribe who carried the slow Met/Met version. They were hypervigilant. They worried about what might happen. They heard a noise outside and sounded the alarm that the group might be under attack. They were the worriers of the tribe.

It was also useful to have people within the tribe who carried the fast Val/Val version. They thrived on danger. They sought out stimulation and had high pain tolerance. They were the warriors and the explorers in the tribe.

These extremes of personality were useful to the collective group when humans lived in interdependent groups. But now, in these modern times, when you have to navigate your own individual life on your own, your natural personality type may be more of a challenge.

Your COMT Speed Can Change Day to Day

Even if you’re genetically slow COMT or fast COMT, your functional COMT speed shifts based on what’s happening in your life right now. Your genetics set the baseline. Your daily choices move the needle.

A slow COMT person who ate a high-protein meal loaded with tyrosine, drank two cups of coffee, got into an argument with their spouse, and then did a hard CrossFit session? They just flooded their system with catecholamines and catechols while simultaneously burning through the magnesium and methyl donors COMT needs to clear them. That person’s COMT is now acting even slower than their genetics alone would predict. They’re going to be wired, irritable, and unable to sleep.

A fast COMT person who skipped breakfast, fasted until 2 p.m., had a low-protein day, and sat at a desk without moving? Their dopamine production is already low — and their fast COMT is clearing what little they make almost immediately. They’re going to feel foggy, flat, and unmotivated.

A woman with slow COMT who is mid-cycle at ovulation, when estrogen peaks? Her COMT is now trying to clear a surge of estrogen on top of its usual catecholamine workload. PMS symptoms, breast tenderness, and anxiety spike — not because something is “wrong,” but because COMT is overwhelmed.

Someone who went on a long, hard run and raised their homocysteine from the exertion? A meta-analysis of 22 studies found that acute exercise increases plasma homocysteine by an average of 1.18 µmol/L, with intensity-dependent effects [14]. That elevated homocysteine signals that methylation is strained — SAM is being consumed faster, SAH (a COMT inhibitor) accumulates, and COMT has fewer methyl groups to work with [15]. Their COMT just got functionally slower — regardless of their genetics.

This is why I always say: you are not your genes. You are how your genes are expressed today. And that changes with every meal, every stressor, every night of sleep, and every choice you make.

Signs and Symptoms of a Dirty COMT

Signs of a Slow COMT (Met/Met or Functionally Slow)

When COMT is slow, dopamine, norepinephrine, and estrogen tend to build up. This often looks like:

  • Mood and brain: Restlessness rumination, overthinking, poor sleep (especially the “can’t shut your brain off” type), irritability, heightened startle response, perfectionism that feels compulsive rather than chosen.
  • Pain and body: Increased pain sensitivity, tension headaches, and jaw clenching. Research consistently links the Met/Met genotype with greater pain severity — one study found Met/Met fibromyalgia patients had significantly worse pain intensity and functional impairment scores than Val/Val carriers[17].
  • Hormonal: PMS, heavy periods, breast tenderness, fibroids, estrogen dominance symptoms, difficulty tolerating hormonal birth control. During postmenopause, COMT variant becomes especially relevant for women considering hormone replacement therapy (HRT). When postmenopausal women received oral estradiol, those with the Met/Met (slow COMT) genotype had significantly higher serum estradiol levels than Val/Val carriers — the enzyme simply couldn't clear the added estrogen as quickly [26]. A separate study of peri- and postmenopausal women found that higher COMT activity was associated with lower severity of somatic menopause symptoms, suggesting the enzyme's clearance capacity directly shapes how a woman experiences the hormonal transition [27], although this effect weakened after adjusting for hormone therapy use. COMT is a gatekeeper enzyme that O-methylates catechol estrogens, blocking their estrogenicity and preventing further oxidation to reactive quinones [3].

The same principle applies to men on testosterone replacement therapy (TRT). Aromatase converts a portion of exogenous testosterone into estradiol — and the higher the testosterone dose, the more aromatization occurs [28]. That estradiol still needs to be hydroxylated and then methylated by COMT to be safely cleared. A man with slow COMT on TRT is essentially flooding an enzyme that already struggles to keep up with estrogen metabolites. This may explain why some men on TRT develop symptoms of estrogen excess — water retention, moodiness, breast tenderness, or gynecomastia — while others on the same dose feel fine. COMT genotype is a missing piece that most TRT protocols never account for.

Stress response: Feeling wired but tired, poor tolerance of caffeine, sensitivity to stimulants, feeling “overstimulated” in loud or busy environments. It takes a long time to calm down from a stressful situation like being pulled over by a police officer.

Signs of a Fast COMT (Val/Val or Functionally Fast)

When COMT clears neurotransmitters too quickly, the picture flips:

  • Mood and brain: Low motivation, flat affect, difficulty focusing or sustaining attention, emotional numbness, tendency to seek stimulation (caffeine, sugar, novelty). Research has shown that Val/Val individuals (with lower prefrontal dopamine) may show poorer executive function and working memory performance in some populations [18], while clinical case studies document improvement in motivation and depression when dopamine levels are supported in Val/Val patients [2].
  • Pain and body: Higher pain tolerance but lower drive and energy, fatigue.
  • Hormonal: Because COMT also degrades estrogen metabolites through O-methylation, fast COMT women clear estrogen from tissues more rapidly [34]. This can worsen low-estrogen symptoms — vaginal dryness, mood changes, and bone loss — particularly around menopause. Studies confirm the connection: in 246 pre-pubertal girls, those with slow COMT were 5.4 cm taller and had 9.8% higher cortical bone mineral content than fast COMT girls, due to prolonged estrogen exposure during bone-building years [34]. A similar pattern was found for peak bone mineral density in young men [35].
  • Stress response: Fast COMT individuals often feel calm under pressure but struggle to get started on tasks in low-stress settings. This is explained by the "Warrior-Worrier" model [36]: the prefrontal cortex needs an optimal level of dopamine to function well, and fast COMT keeps baseline dopamine below that sweet spot. Stress raises dopamine — which actually improves performance for Val/Val individuals. A landmark study of 140 adults confirmed this directly: Val/Val individuals performed better on cognitive tasks when mildly stressed, while Met carriers performed worse [37]. A separate study found that the Met allele was significantly associated with initiating and completing tasks on time, while Val carriers showed greater procrastination tendency — likely because they need deadline pressure to reach optimal dopamine levels [38].

Core Lab Tests

Homocysteine. This is one of the most useful markers for understanding COMT function. When homocysteine is elevated, it signals that your methylation cycle is strained — which means SAM production is compromised, which means COMT doesn’t have the methyl groups it needs to do its job. Elevated homocysteine leads to accumulation of S-adenosylhomocysteine (SAH), which is a direct inhibitor of COMT and most other cellular methyltransferases [15]. High homocysteine effectively makes your COMT slower, regardless of your genetics. Optimal is between 6–8 µmol/L. If yours is above 10, your COMT is most likely underperforming.

Urinary Catecholamines (dopamine, norepinephrine, epinephrine). This test measures the levels of your primary catecholamines in urine, giving you a snapshot of whether your body is producing and clearing these neurotransmitters effectively. You want to see values in the middle of the reference range — not piled up at the high end (suggesting slow clearance) or bottomed out (suggesting fast clearance).

Estrogen Metabolites (2-OH, 4-OH, 16-OH estrogens via DUTCH test or similar). COMT is responsible for methylating and clearing estrogen metabolites. The DUTCH test shows whether your 2-OH and 4-OH estrogens are being properly methylated. You want to see adequate 2-methoxy estrogen levels, which signals that COMT is doing its job. Low methylation of 4-OH estrogen is a red flag — the Met variant is approximately three times less active in methylating 4-OH estradiol to its protective methoxy form [19].

RBC Magnesium. Since magnesium is a direct cofactor for COMT, knowing your magnesium status matters. Standard serum magnesium misses intracellular deficiency. RBC magnesium is more accurate. Optimal is above 5.0 mg/dL — not just “within range.”

How to Clean Up Your COMT Gene

Lifestyle

Practice stress regulation daily as a non-negotiable. For slow COMT, calming practices are essential: 10 minutes of slow diaphragmatic breathing in the morning, restorative yoga, walking in nature, and strict limits on screen time before bed.

For fast COMT, moderate stimulation can actually help, such as brisk exercise, cold plunges, music, dancing, cold-water face splashes, and engaging tasks that build dopamine naturally.

Prioritize sleep. COMT-related neurotransmitter imbalances hit hardest when you’re sleep-deprived. Aim for a consistent bedtime, keep your room cool and dark, and stop caffeine by noon or altogether if you’re slow COMT as caffeine makes you wired and unable to sleep.

Food

For slow COMT, reduce catechol-rich foods such as coffee, green tea, dark chocolate, and red wine. These add to COMT’s workload. Increase magnesium-rich foods such as pumpkin seeds, dark leafy greens, almonds and eat plenty of cruciferous vegetables (broccoli, cauliflower, Brussels sprouts) to support healthy estrogen metabolism through DIM and sulforaphane pathways. Reduce your protein intake at dinner and no protein within a few hours of bedtime. Protein leads to neurotransmitter formation which a slow COMT struggles with. Time-restricted feeding could be great for you. Aim for 16 hours of no food and an 8 hour feeding window. I like using the app Zero.

For fast COMT, protein protein protein. You must eat breakfast and protein with each meal. Moderate amounts of green tea and catechol-containing foods may actually be supportive, as they provide gentle catecholamine stimulation. Don’t skip meals and don’t go long periods without protein — your fast COMT is already clearing dopamine rapidly, and low protein intake means you’re not even making enough to keep up. This is the biggest factor for you.

For intermediate COMT, balance your protein intake and adjust how you feel. If you’re starting to get that cold, hangry feeling, you waited too long to eat protein. If you’re not hungry and in a good mood, have lighter protein or skip the meal altogether.

Environment

Reduce xenoestrogen exposure. Switch to glass food containers instead of plastic. Choose fragrance-free personal care products. Filter your drinking water. Avoid handling thermal receipts (BPA source). Check your household cleaning products and replace synthetic-fragrance sprays and plugins with simple alternatives like diluted essential oils or open windows. Do not use scented products.

These changes reduce the total estrogenic burden on COMT, freeing it up to handle its primary job of clearing neurotransmitters.

Supplements to Support a Fast COMT

If you’ve addressed diet, lifestyle, and environmental factors and still need support, these Seeking Health supplements are formulated to help when COMT is clearing neurotransmitters too quickly:

Dopamine Nutrients Provides the precursors and cofactors your body needs to produce dopamine, including tyrosine, key B vitamins, and supporting nutrients. When your COMT is fast, your brain clears dopamine almost as quickly as it makes it. Dopamine Nutrients helps focus, drive, and mental clarity. Ideal for those who feel low on motivation, mentally sluggish, or dependent on caffeine and sugar for a boost.. This is a foundational place to begin.*

Supplement bottle labeled 'Brain Nutrients' on a white background

Brain Nutrients If you're taking Dopamine Nutrients and not feeling much benefit, the need may be upstream. Your body needs biopterin (BH4) as a cofactor to actually produce dopamine and norepinephrine — without enough BH4, having the right precursors won't matter. Brain Nutrients supports biopterin synthesis along with broad-spectrum neurotransmitter production. Stack it with Dopamine Nutrients if you're not getting results from Dopamine Nutrients alone. If Dopamine Nutrients is already working well for you, Brain Nutrients isn't needed.*

Supplements to Support a Slow COMT

If your COMT is slow, either genetically or functionally, the goal is to support the enzyme’s ability to clear catecholamines and estrogen, calm the nervous system, and reduce the total burden on COMT:

Optimal Magnesium

Optimal Magnesium Provides highly absorbable magnesium in forms that support COMT enzyme function directly. Magnesium is the essential cofactor for COMT — the enzyme needs it to work, regardless of your genetics [4, 5]. Most people are deficient, and slow COMT individuals tend to burn through magnesium even faster under stress. This is the first supplement to reach for.*

DIM + I3C Supports healthy estrogen metabolism through a pathway that complements COMT’s role in estrogen clearance. When COMT is slow, estrogen metabolites can accumulate and contribute to PMS, breast tenderness, heavy periods, and long-term hormonal concerns. DIM + I3C helps your body process estrogen through alternative routes, supporting COMT. Ideal for women experiencing estrogen dominance symptoms alongside a slow COMT.*

Stress Nutrients Formulated to support your body’s stress response with targeted B vitamins, adaptogens, and calming nutrients. Slow COMT means catecholamines are already running high — and when stress piles on top, those levels climb even further. Stress Nutrients help your body process and respond to stress efficiently, which can directly change the demand on COMT. Best for those who feel wired, restless, and unable to wind down.*

Want to Know If Your COMT Is Born Dirty?

StrateGene Genetic Pathway Analysis report on a laptop with an apple in the background

StrateGene is Seeking Health’s comprehensive genetic analysis tool — and it goes far beyond telling you whether you have a COMT variant. StrateGene maps how your COMT gene interacts with your other genes, your methylation cycle, and your neurotransmitter pathways, giving you a complete picture rather than isolated SNPs. It translates your raw genetic data into an actionable roadmap you can actually use. Order StrateGene at seekinghealth.com/strategene to see your COMT variants and get a personalized roadmap.

Learn More — Read Dirty Genes

COMT is one of the Super Seven genes covered in depth in Dirty Genes by Dr. Ben Lynch. The book walks you through exactly how COMT gets dirty, how it interacts with your other genes, and gives you a complete Soak and Scrub protocol designed to clean it up — step by step. If this page resonated with you, the book will take you to the next level of understanding your own biochemistry. Available wherever books are sold, or visit seekinghealth.com/dirty-genes.

Image of Dirty Genes by Dr Ben Lynch

References

  1. Axelrod J, Tomchick R. “Enzymatic O-methylation of epinephrine and other catechols.” Journal of Biological Chemistry. 1958;233(3):702-705.
  2. Frank MJ, Fossella JA. “Neurogenetics and pharmacology of learning, motivation, and cognition.” Neuropsychopharmacology. 2011;36:133-152. doi:10.1038/npp.2010.96
  3. Yager JD. “Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer.” Breast Cancer Research. 2012;14(4):R27. PMC3455752.
  4. Rutherford K, Le Trong I, Stenkamp RE, Parson WW. “Crystal structures of human 108V and 108M catechol O-methyltransferase.” Journal of Molecular Biology. 2008;380(1):120-130. Also reviewed in: Kiss LE, Soares-da-Silva P. “Recent progress in synthetic and natural catechol-O-methyltransferase inhibitors for neurological disorders.” ACS Omega. 2024. doi:10.1021/acsomega.4c06190
  5. Ushijima K, et al. “Dietary magnesium insufficiency induces salt-sensitive hypertension in mice associated with reduced kidney catechol-O-methyl transferase activity.” Hypertension. 2021;78:798-810. doi:10.1161/HYPERTENSIONAHA.120.16377. Also: Ushijima K, et al. “Empagliflozin reduces liver fibrosis by restoring catechol-O-methyltransferase activity associated with magnesium levels.” Scientific Reports. 2025;15:25645. doi:10.1038/s41598-025-12813-x
  6. Zhu BT, Wang P, Nagai M, Wen Y, Bai HW. Inhibition of human catechol-O-methyltransferase (COMT)-mediated O-methylation of catechol estrogens by major polyphenolic components present in coffee. BMC Biochemistry. 2009;10:16. doi:10.1186/1471-2091-10-16
  7. Chen J, Lipska BK, Halim N, et al. “Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain.” American Journal of Human Genetics. 2004;75(5):807-821. doi:10.1086/425589
  8. Elsayed NM, et al. “Potential impact of COMT-rs4680 G > A gene polymorphism in coronary artery disease.” Journal of Cardiovascular Development and Disease. 2018;5(3):38. doi:10.3390/jcdd5030038
  9. Dahmardeh F, Rezaeifar A. “Effect of rs4680 (Val158Met) polymorphism of the COMT gene on opioid addiction in an Iranian population.” Gene, Cell and Tissue. 2019;6(2):e91912. doi:10.5812/gct.91912
  10. Wichers M, et al. “The catechol-O-methyl transferase Val158Met polymorphism and experience of reward in the flow of daily life.” Neuropsychopharmacology. 2008;33(13):3030-3036.
  11. Nackley AG, et al. “Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure.” Science. 2006;314(5807):1930-1933.
  12. Palmatier MA, Kang AM, Kidd KK. “Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.” Biological Psychiatry. 1999;46(4):557-567.
  13. Taylor S. “Association between COMT Val158Met and psychiatric disorders: a comprehensive meta-analysis.” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2018;177(2):199-210. doi:10.1002/ajmg.b.32556
  14. Deminice R, et al. “The effects of acute exercise and exercise training on plasma homocysteine: a meta-analysis.” PLoS ONE. 2016;11(3):e0151653. doi:10.1371/journal.pone.0151653
  15. Barroso M, Handy DE, Castro R. “The link between hyperhomocysteinemia and hypomethylation: implications for cardiovascular disease.” Journal of Inborn Errors of Metabolism and Screening. 2017;5:1-11. doi:10.1177/2326409817698994
  16. Domschke K, Deckert J, et al. “Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity.” American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2007;144B(5):667-673. doi:10.1002/ajmg.b.30494
  17. Barbosa FR, et al. “The polymorphism Val158Met in the COMT gene: disrupted modulation in fibromyalgia.” PAIN. 2024;165(12):e149-e158. doi:10.1097/j.pain.0000000000003320
  18. Sheldrick AJ, et al. “Effect of COMT val158met genotype on cognition and personality.” European Psychiatry. 2008;23(6):385-389. doi:10.1016/j.eurpsy.2008.05.002
  19. Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. “Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.” Cancer Research. 2001;61(18):6716-6722.
  20. He XF, Wei W, Li JL, et al. “Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.” Diagnostic Pathology. 2012;7:136. doi:10.1186/1746-1596-7-136
  21. Zubieta JK, et al. “COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor.” Science. 2003;299(5610):1240-1243.
  22. https://pubmed.ncbi.nlm.nih.gov/?term=COMT
  23. Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutrition Reviews. 2012;70(3):153-164. doi:10.1111/j.1753-4887.2011.00465.x
  24. Baune BT, Hohoff C, Berger K, et al. Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology. 2008;33(4):924-932. doi:10.1038/sj.npp.1301462
  25. Venter G, van der Berg CL, Jacobs T, van der Westhuizen FH, Erasmus E. Oral contraceptives containing ethinyl estradiol and drospirenone increase hydroxylation and methylation of endogenous estrogen but not genotoxic estrogen DNA-adduct formation. Scientific Reports. 2025;15:31468. doi:10.1038/s41598-025-16892-8
  26. Worda C, Sator MO, Schneeberger C, Tempfer C, Huber JC, Nagele F. Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Human Reproduction. 2003;18(2):262-266. doi:10.1093/humrep/deg059
  27. Bielinski SJ, Kolbe AB, Engel K, et al. The effect of genetic variation in estrogen transportation and metabolism on the severity of menopause symptoms: a study from the RIGHT 10K cohort. Menopause. 2023;30(10):1019-1025. doi:10.1097/GME.0000000000002234
  28. Tan RS, Cook KR, Reilly WG. High estrogen in men after injectable testosterone therapy: the low T experience. American Journal of Men's Health. 2015;9(3):229-234. doi:10.1177/1557988314539000
  29. Eriksson AL, Suuriniemi M, Mahonen A, Cheng S, Ohlsson C. The COMT val158met polymorphism is associated with early pubertal development, height and cortical bone mass in girls. Pediatric Research. 2005;58(1):71-77.
  30. Lorentzon M, Eriksson AL, Mellström D, Ohlsson C. The COMT val158met polymorphism is associated with peak BMD in men. Journal of Bone and Mineral Research. 2004;19(12):2005-2011.
  31. Goldman D, Oroszi G, Ducci F. The genetics of addictions: uncovering the genes. Nature Reviews Genetics. 2005;6(7):521-532.
  32. Zareyan S, Zhang H, Wang J, et al. First demonstration of double dissociation between COMT-Met158 and COMT-Val158 cognitive performance when stressed and when calmer. Cerebral Cortex. 2021;31(3):1411-1426.
  33. Di Nocera F, Ricciardi O, Abate G, Bevilacqua A. Does the catechol-O-methyltransferase (COMT) Val158Met human polymorphism influence procrastination? Organisms: Journal of Biological Sciences. 2017;1(2):27-36.
  34. Kolassa IT, Kolassa S, Ertl V, Papassotiropoulos A, De Quervain DJ. The risk of posttraumatic stress disorder after trauma depends on traumatic load and the catechol-O-methyltransferase Val(158)Met polymorphism. Biological Psychiatry. 2010;67(4):304-308.
  35. Deslauriers J, Bhatt S, Bhakta S, Acheson DT, Risbrough VB. COMT val158met polymorphism links to altered fear conditioning and extinction are modulated by PTSD and childhood trauma. Psychological Medicine. 2018;48(10):1-11.
  36. Bäckström D, Granasen G, Domellöf ME, et al. Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease. Acta Neurologica Scandinavica. 2018;137(1):91-98.